iShares Genomics Immunology and Healthcare ETF Rating $21.15 -0.10 (-0.47%) Closing price 08/1/2025 04:10 PM EasternExtended Trading$21.19 +0.04 (+0.19%) As of 08/1/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsShort InterestBuy This Stock iShares Genomics Immunology and Healthcare ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IDNA Aggregate RatingModerate Buy 2.67Holdings in IDNA have an aggregate rating of Moderate Buy based on 231 analyst ratings issued in the past year covering 17 companies (56.2% of the portfolio).IDNA Aggregate Price Target$21.15High Prediction$21.15Average Prediction$21.15Low Prediction$21.15Holdings in IDNA have an aggregate price target of $21.15 and a range of $21.15 to $21.15 covering 17 companies (56.2% of the portfolio).IDNA Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy6 Buy rating(s)Moderate Buy6 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares Genomics Immunology and Healthcare ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 17 IDNA Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings4.58%REGNRegeneron Pharmaceuticals$558.87+2.5%4.9306 of 5 stars2.75$828.86 48.3%24Trending NewsAnalyst ForecastGap Up4.51%INCYIncyte$75.59+0.9%4.751 of 5 stars2.28$79.73 5.5%18Trending NewsAnalyst Forecast4.46%MRNAModerna$27.60-6.6%4.3836 of 5 stars2.04$46.11 67.1%25Trending NewsEarnings ReportAnalyst ForecastOptions VolumeGap Down4.40%TWSTTwist Bioscience$33.68+0.3%3.5282 of 5 stars2.70$50.40 49.6%10Short Interest ↑Gap Down4.34%ACLXArcellx$71.14-0.4%2.5831 of 5 stars3.07$114.31 60.7%15News CoveragePositive NewsAnalyst Forecast4.10%BNTXBioNTech$107.34-0.1%2.905 of 5 stars2.76$136.58 27.2%17News CoverageUpcoming EarningsGap Down4.10%MRKMerck & Co., Inc.$79.27+1.5%4.997 of 5 stars2.35$107.44 35.5%20Trending NewsEarnings ReportAnalyst Revision3.76%RVMDRevolution Medicines$36.63-1.7%4.4879 of 5 stars3.00$68.91 88.1%11News CoverageUpcoming Earnings3.49%EXELExelixis$37.26+2.9%4.9468 of 5 stars2.55$44.44 19.3%22Trending NewsEarnings ReportAnalyst ForecastOptions VolumeAnalyst Revision3.05%BCRXBioCryst Pharmaceuticals$7.95-2.3%4.3027 of 5 stars2.90$16.70 110.1%10High Trading Volume2.83%CELCCelcuity$39.91+1.9%0.857 of 5 stars3.00$39.20 -1.8%52.78%JANXJanux Therapeutics$23.56-1.9%2.852 of 5 stars3.08$91.89 290.0%12Positive NewsUpcoming Earnings2.34%ABCLAbCellera Biologics$4.24-5.1%2.4143 of 5 stars3.00$8.75 106.4%6Upcoming EarningsGap Down2.30%NVAXNovavax$6.56-1.4%4.574 of 5 stars2.25$15.86 141.7%8News CoverageUpcoming EarningsGap Down1.89%IMNMImmunome$10.59+0.7%1.9821 of 5 stars3.00$23.33 120.3%6Positive NewsUpcoming EarningsGap Down1.63%IOVAIovance Biotherapeutics$2.68+4.3%4.4639 of 5 stars2.33$12.22 356.1%12Upcoming EarningsGap Down1.62%GERNGeron$1.17+1.7%3.0325 of 5 stars2.60$4.61 294.1%10Upcoming Earnings This page (NYSEARCA:IDNA) was last updated on 8/4/2025 by MarketBeat.com Staff From Our PartnersThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | Sponsored[Warning] Buffett Indicator hits new All-Time-HighWarren Buffett has leaned on one key indicator for decades—and it just hit an all-time high. That’s not bullis...Golden Portfolio | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | SponsoredTrump’s crypto advisor may have revealed the next big crypto opportunityWhile investors chase Bitcoin toward $100K, D.C. insiders are quietly loading up on something else. One of Tru...Weiss Ratings | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Genomics Immunology and Healthcare ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Genomics Immunology and Healthcare ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
